title: Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide.
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: E
authors: E
authors: Negoro
authors: Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
authors: T
authors: T
authors: Radivoyevitch
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: C
authors: C
authors: Polprasert
authors: Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
authors: V
authors: V
authors: Adema
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: N
authors: N
authors: Hosono
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.|Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors: H
authors: H
authors: Makishima
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: B
authors: B
authors: Przychodzen
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: C
authors: C
authors: Hirsch
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: M J
authors: MJ
authors: Clemente
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: A
authors: A
authors: Nazha
authors: Hematology Unit, AOU Careggi, University of Florence, Firenze, Italy.
authors: V
authors: V
authors: Santini
authors: Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
authors: K L
authors: KL
authors: McGraw
authors: Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
authors: A F
authors: AF
authors: List
authors: Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
authors: F
authors: F
authors: Sole
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: M A
authors: MA
authors: Sekeres
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
authors: J P
authors: JP
authors: Maciejewski
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002895:Chromosomes, Human, Pair 5; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide